effect of Indigenous compound in cases of Tamak Shwas.

Phase 2

Completed

• Conditions: Health Condition 1: null- As mentioned in inclusion critaria

• Registration Number: CTRI/2018/02/011864
• Lead Sponsor: Dept of Kayachikitsa

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2016-06-16
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 3

Inclusion Criteria

1- Intermittent and mild persistent cases of asthma.

2- Symptoms according to Ch.Chi.17/56-62 (4 essential + any >=2 other symptoms mention bellow)

Essential Symptoms

a- Rapidity of breathing

b- Cough

c- Rottling

d- Severe breathlessness if sputum is not expectorated out, slight relief in breathlessness on spitting out the sputum

Other Symptoms

a- Breathlessness disturbs sleep

b- Sweating in the forehead

c- Symptoms aggravated by environmental condition such as- cloud, cold water, morning time cold air and taking kaph vardhak diets

d- Likes hot thing

Exclusion Criteria

1. Moderate persistent, severe persistent asthma.

2. Dyspnoea due to other disease like- LVF, COPD, Upper respiratory tract obstruction, Bronchiectasis, Tuberculosis, Interstitial lung disease, Tropical pulmonary eosinophilia etc.

3. Uncontrolled diabetes mellitus, hypertension and any other systemic disorders.

4. Pregnant or lactating mother.

5. Symptoms (mention in inclusion criteria according to Ch.Chi.17/56-62) <4 essential or 4 essential + <2 other symptoms).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ew easily available economical and safe drug for asthmaTimepoint: 2 months

Secondary Outcome Measures

Name	Time	Method
To check the disease process or complication of Intermittent and mild persistent cases of asthma.Timepoint: 2 Month